T1	PROC 44 68	Estudio de investigación
#1	AnnotatorNotes T1	C0681814; research study; Research Activity
T2	PROC 77 88	tratamiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 117 140	leucemia mieloide aguda
#3	AnnotatorNotes T3	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T4	PROC 177 186	Protocolo
#4	AnnotatorNotes T4	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T5	PROC 206 230	Estudio de investigación
#5	AnnotatorNotes T5	C0681814; research study; Research Activity
T6	PROC 239 250	tratamiento
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 279 302	leucemia mieloide aguda
#7	AnnotatorNotes T7	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T8	DISO 340 363	Leucemia Mieloide Aguda
#8	AnnotatorNotes T8	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T9	DISO 393 396	LMA
#9	AnnotatorNotes T9	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T10	PROC 435 446	diagnóstico
#10	AnnotatorNotes T10	C0011900; Diagnosis; Diagnostic Procedure
T11	PROC 500 511	diagnóstico
#11	AnnotatorNotes T11	C0011900; Diagnosis; Diagnostic Procedure
T12	PROC 578 591	Quimioterapia
#12	AnnotatorNotes T12	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T13	PROC 594 606	radioterapia
#13	AnnotatorNotes T13	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T14	PROC 515 539	Consentimiento Informado
#14	AnnotatorNotes T14	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T15	DISO 642 656	LMA secundaria
#15	AnnotatorNotes T15	C0280449; Secondary Acute Myeloid Leukemia; Neoplastic Process
T16	PROC 672 691	terapia anti cáncer
T17	DISO 685 691	cáncer
#16	AnnotatorNotes T17	C0006826; Malignant Neoplasms; Neoplastic Process
T18	PROC 744 753	protocolo
#17	AnnotatorNotes T18	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T19	PROC 717 725	tratados
#18	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	DISO 807 821	LMA secundaria
#19	AnnotatorNotes T20	C0280449; Secondary Acute Myeloid Leukemia; Neoplastic Process
T21	PROC 852 865	quimioterapia
#20	AnnotatorNotes T21	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T22	PROC 895 922	trasplante de células madre
#21	AnnotatorNotes T22	C1504389; Stem cell transplant; Therapeutic or Preventive Procedure
T23	DISO 959 973	LMA secundaria
#22	AnnotatorNotes T23	C0280449; Secondary Acute Myeloid Leukemia; Neoplastic Process
T24	DISO 984 1027	síndrome de insuficiencia de la médula ósea
#23	AnnotatorNotes T24	C2931245; Bone Marrow Failure Disorders; Disease or Syndrome
T25	ANAT 1016 1027	médula ósea
#24	AnnotatorNotes T25	C0005953; Bone Marrow; Tissue
T26	DISO 1032 1048	Síndrome de Down
#25	AnnotatorNotes T26	C0013080; Down Syndrome; Disease or Syndrome
T27	DISO 1050 1052	SD
#26	AnnotatorNotes T27	C0013080; Down Syndrome; Disease or Syndrome
T28	DISO 1065 1081	Síndrome de Down
#27	AnnotatorNotes T28	C0013080; Down Syndrome; Disease or Syndrome
T29	DISO 1086 1103	Leucemia mieloide
#28	AnnotatorNotes T29	C0023470; Myeloid Leukemia; Neoplastic Process
T30	PROC 1158 1167	protocolo
#29	AnnotatorNotes T30	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T31	PROC 1131 1139	tratados
#30	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	DISO 1203 1206	LMA
#31	AnnotatorNotes T32	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T33	DISO 1209 1211	SD
#32	AnnotatorNotes T33	C0013080; Down Syndrome; Disease or Syndrome
T34	DISO 1287 1310	leucemia mieloide aguda
#33	AnnotatorNotes T34	C0023467; Leukemia, Myelocytic, Acute; Neoplastic Process
T35	DISO 1314 1330	síndrome de Down
#34	AnnotatorNotes T35	C0013080; Down Syndrome; Disease or Syndrome
T36	PROC 1366 1375	protocolo
#35	AnnotatorNotes T36	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T37	PROC 1343 1351	tratados
#36	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	DISO 1438 1467	Leucemia promielocítica aguda
#37	AnnotatorNotes T38	C0023487; Acute Promyelocytic Leukemia; Neoplastic Process
T39	PROC 1510 1521	tratamiento
#38	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T40	DISO 1260 1268	mutación
T41	DISO 1562 1565	LPA
#39	AnnotatorNotes T41	C0023487; Acute Promyelocytic Leukemia; Neoplastic Process
T42	DISO 1569 1593	Síndrome Mielodisplásico
#40	AnnotatorNotes T42	C0026985; Myelodysplasia; Congenital Abnormality | C3463824; MYELODYSPLASTIC SYNDROME; Neoplastic Process
T43	DISO 1595 1598	SMD
#41	AnnotatorNotes T43	C0026985; Myelodysplasia; Congenital Abnormality | C3463824; MYELODYSPLASTIC SYNDROME; Neoplastic Process
T44	PROC 1642 1653	tratamiento
#42	AnnotatorNotes T44	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T45	DISO 1683 1715	Leucemia Mielomonocítica Juvenil
#43	AnnotatorNotes T45	C0349639; Juvenile Myelomonocytic Leukemia; Neoplastic Process
T46	DISO 1717 1721	LMMJ
#44	AnnotatorNotes T46	C0349639; Juvenile Myelomonocytic Leukemia; Neoplastic Process
T47	PROC 1765 1776	tratamiento
#45	AnnotatorNotes T47	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T48	CHEM 1843 1849	drogas
#46	AnnotatorNotes T48	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T49	PROC 1853 1866	quimioterapia
#47	AnnotatorNotes T49	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T50	PROC 1883 1892	protocolo
#48	AnnotatorNotes T50	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T51	DISO 1897 1914	Anemia de Fanconi
#49	AnnotatorNotes T51	C0015625; Fanconi Anemia; Disease or Syndrome
T52	PROC 1960 1991	administración de quimioterapia
T53	PROC 2009 2025	Test de embarazo
#50	AnnotatorNotes T53	C0032976; Pregnancy Tests; Diagnostic Procedure
T54	PROC 2120 2141	método anticonceptivo
#51	AnnotatorNotes T54	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T55	ANAT 126 134	mieloide
#52	AnnotatorNotes T55	C0229619; Hemopoietic tissue; Tissue
T56	ANAT 288 296	mieloide
#53	AnnotatorNotes T56	C0229619; Hemopoietic tissue; Tissue
T57	ANAT 349 357	Mieloide
#54	AnnotatorNotes T57	C0229619; Hemopoietic tissue; Tissue
T58	PROC 929 942	procedimiento
#55	AnnotatorNotes T58	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T59	ANAT 909 922	células madre
#56	AnnotatorNotes T59	C0038250; Stem cells; Cell
T60	ANAT 1095 1103	mieloide
#57	AnnotatorNotes T60	C0229619; Hemopoietic tissue; Tissue
T61	ANAT 1296 1304	mieloide
#58	AnnotatorNotes T61	C0229619; Hemopoietic tissue; Tissue
T62	DISO 1805 1817	Intolerancia
#59	AnnotatorNotes T62	C0277585; Intolerance to drug; Pathologic Function
T63	DISO 1919 1933	Fallo orgánico
T64	Date 12 16	2012
T65	LIVB 92 97	niños
#60	AnnotatorNotes T65	C0008059; Child; Age Group
T66	Age 141 155	de 0 a 18 años
T67	LIVB 254 259	niños
#61	AnnotatorNotes T67	C0008059; Child; Age Group
T68	Age 303 317	de 0 a 18 años
T69	Age 472 481	< 19 años
T70	LIVB 628 637	pacientes
#62	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T75	LIVB 1055 1064	Pacientes
#63	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T76	LIVB 1189 1198	Pacientes
#64	AnnotatorNotes T76	C0030705; Patients; Patient or Disabled Group
T77	Age 1212 1229	mayores de 5 años
T78	Neg_cue 1277 1279	no
T81	LIVB 1475 1484	pacientes
#65	AnnotatorNotes T81	C0030705; Patients; Patient or Disabled Group
T82	LIVB 1607 1616	pacientes
#66	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T83	LIVB 1730 1739	pacientes
#67	AnnotatorNotes T83	C0030705; Patients; Patient or Disabled Group
T84	Neg_cue 1945 1956	descartando
T85	LIVB 2039 2070	Mujeres en periodo de lactancia
#68	AnnotatorNotes T85	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T86	LIVB 2073 2095	mujeres en edad fértil
#69	AnnotatorNotes T86	C4324275; Woman of childbearing potential; Population Group
T87	Age 2084 2095	edad fértil
T88	PHYS 2061 2070	lactancia
#70	AnnotatorNotes T88	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T89	Neg_cue 2100 2102	no
T90	LIVB 100 112	adolescentes
#71	AnnotatorNotes T90	C0205653; Adolescent (age group); Age Group
T91	LIVB 262 274	adolescentes
#72	AnnotatorNotes T91	C0205653; Adolescent (age group); Age Group
T92	LIVB 785 805	población de estudio
#73	AnnotatorNotes T92	C2348561; Study Population (group); Population Group
T94	LIVB 1412 1433	población del estudio
#74	AnnotatorNotes T94	C2348561; Study Population (group); Population Group
T96	PHYS 2017 2025	embarazo
#75	AnnotatorNotes T96	C0032961; Pregnancy; Organism Function
T71	GENE 1269 1274	GATA1
#76	AnnotatorNotes T71	C1333663; GATA1 gene; Gene or Genome
A1	Population_data T65 Age
A2	Population_data T90 Age
A3	Population_data T67 Age
A4	Population_data T91 Age
A5	Assertion T34 Negated
A6	Assertion T52 Negated
A7	Assertion T54 Negated
A8	Status T13 History_of
A9	Status T12 History_of
A10	Status T16 History_of
A11	Status T62 History_of
#77	AnnotatorNotes T40	C1705285; Mutation Abnormality; Cell or Molecular Dysfunction
#78	AnnotatorNotes T52	C3665478; chemotherapy administration; Health Care Activity
T72	Neg_cue 760 762	no
T73	Observation 769 805	incluidos en la población de estudio
A12	Assertion T73 Negated
#79	AnnotatorNotes T73	C1302261; Patient eligible for clinical trial; Finding (?)
T74	Observation 1396 1433	incluidos en la población del estudio
A13	Assertion T74 Negated
#80	AnnotatorNotes T74	C1302261; Patient eligible for clinical trial; Finding (?)
T79	Neg_cue 1382 1384	no
R1	Negation Arg1:T72 Arg2:T73	
T80	Spec_cue 872 877	puede
T93	Observation 878 890	beneficiarse
A14	Assertion T93 Speculated
#81	AnnotatorNotes T93	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R2	Speculation Arg1:T80 Arg2:T93	
R3	Negation Arg1:T78 Arg2:T34	
R4	Negation Arg1:T79 Arg2:T74	
R5	Negation Arg1:T84 Arg2:T52	
R6	Negation Arg1:T89 Arg2:T54	
T95	Neg_cue 1246 1256	carecen de
R7	Negation Arg1:T95 Arg2:T40	
A15	Assertion T40 Negated
R8	Used_for Arg1:T48 Arg2:T49	
R9	Causes Arg1:T48 Arg2:T62	
R10	Experiences Arg1:T65 Arg2:T2	
R11	Experiences Arg1:T90 Arg2:T2	
R12	Experiences Arg1:T65 Arg2:T3	
R13	Experiences Arg1:T90 Arg2:T3	
R14	Location_of Arg1:T55 Arg2:T3	
R15	Has_Age Arg1:T65 Arg2:T66	
R16	Has_Age Arg1:T90 Arg2:T66	
R17	Experiences Arg1:T67 Arg2:T6	
R18	Experiences Arg1:T91 Arg2:T6	
R19	Experiences Arg1:T67 Arg2:T7	
R20	Has_Age Arg1:T67 Arg2:T68	
R21	Experiences Arg1:T91 Arg2:T7	
R22	Has_Age Arg1:T91 Arg2:T68	
R23	Location_of Arg1:T56 Arg2:T7	
R24	Location_of Arg1:T57 Arg2:T8	
R25	Overlap Arg1:T11 Arg2:T69	
R26	Experiences Arg1:T70 Arg2:T15	
R27	After Arg1:T15 Arg2:T16	
R28	Experiences Arg1:T70 Arg2:T17	
R29	Experiences Arg1:T70 Arg2:T16	
#82	AnnotatorNotes T16	C0920425; cancer treatment; Therapeutic or Preventive Procedure
R30	Experiences Arg1:T92 Arg2:T19	
T97	Observation 832 846	peor respuesta
R33	Overlap Arg1:T97 Arg2:T21	
R34	Before Arg1:T20 Arg2:T97	
R35	Before Arg1:T22 Arg2:T93	
T98	Observation 946 954	tolerado
R36	Overlap Arg1:T58 Arg2:T98	
R37	Overlap Arg1:T22 Arg2:T98	
R38	Before Arg1:T58 Arg2:T93	
R39	Before Arg1:T23 Arg2:T24	
R40	Location_of Arg1:T25 Arg2:T24	
R41	Experiences Arg1:T75 Arg2:T28	
R42	Overlap Arg1:T28 Arg2:T29	
R43	Location_of Arg1:T60 Arg2:T29	
R44	Experiences Arg1:T75 Arg2:T29	
R45	Experiences Arg1:T75 Arg2:T31	
R46	Before Arg1:T20 Arg2:T93	
R47	Experiences Arg1:T76 Arg2:T32	
R48	Experiences Arg1:T76 Arg2:T33	
R49	Has_Age Arg1:T76 Arg2:T77	
R50	Experiences Arg1:T76 Arg2:T40	
R51	Location_of Arg1:T71 Arg2:T40	
R52	Location_of Arg1:T61 Arg2:T34	
R53	Experiences Arg1:T76 Arg2:T34	
R54	Overlap Arg1:T32 Arg2:T33	
R55	Overlap Arg1:T33 Arg2:T40	
R56	Overlap Arg1:T32 Arg2:T40	
R57	Overlap Arg1:T34 Arg2:T35	
R58	Experiences Arg1:T76 Arg2:T35	
R59	Experiences Arg1:T76 Arg2:T37	
R60	Has_Quantifier_or_Qualifier Arg1:T76 Arg2:T74	
R61	Overlap Arg1:T40 Arg2:T34	
R62	Experiences Arg1:T81 Arg2:T39	
R63	Experiences Arg1:T81 Arg2:T41	
R64	Experiences Arg1:T82 Arg2:T44	
R65	Experiences Arg1:T83 Arg2:T47	
T99	Quantifier_or_Qualifier 1992 2003	planificada
A16	Assertion T99 Negated
#83	AnnotatorNotes T99	C1301732; Planned; Functional Concept
R66	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T99	
R67	Negation Arg1:T84 Arg2:T99	
#84	AnnotatorNotes T63	C0561718; Organ failure status; Finding
T100	Quantifier_or_Qualifier 1934 1944	importante
#85	AnnotatorNotes T100	C3898777; Important; Qualitative Concept
R68	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T100	
T101	Result_or_Value 2026 2034	positivo
#86	AnnotatorNotes T101	C1446409; Positive; Finding
R70	Has_Result_or_Value Arg1:T53 Arg2:T101	
R71	Experiences Arg1:T85 Arg2:T88	
R72	Has_Age Arg1:T86 Arg2:T87	
R73	Experiences Arg1:T86 Arg2:T54	
R31	Experiences Arg1:T94 Arg2:T37	
R74	Experiences Arg1:T94 Arg2:T35	
R75	Experiences Arg1:T94 Arg2:T34	
R76	Experiences Arg1:T94 Arg2:T40	
R77	Has_Age Arg1:T94 Arg2:T77	
R78	Experiences Arg1:T94 Arg2:T33	
R79	Experiences Arg1:T94 Arg2:T32	
A17	Assertion T98 Hypothetical
A18	Experiencer T92 Patient
A19	Experiencer T70 Patient
A20	Experiencer T65 Patient
A21	Experiencer T90 Patient
A22	Experiencer T67 Patient
A23	Experiencer T91 Patient
A24	Experiencer T75 Patient
A25	Experiencer T76 Patient
A26	Experiencer T94 Patient
A27	Experiencer T81 Patient
A28	Experiencer T82 Patient
A29	Experiencer T83 Patient
A30	Experiencer T85 Patient
A31	Experiencer T86 Patient
A32	Status T52 Future
